Literature DB >> 23299562

Disease-specific quality-of-life questionnaires in rhinitis and rhinosinusitis: review and evaluation.

Dirk A E Dietz de Loos1, Christine L Segboer, Artur Gevorgyan, Wytske J Fokkens.   

Abstract

Quality of life (QoL) measurements are the best approximation of the burden of disease for the patient. Patient-reported outcome measurements (PROMs) estimate health-related quality of life (HRQoL). PROMs can be generic or disease-specific. Generic PROMs allow comparisons between different diseases but can be relatively insensitive for measuring changes within a disease. Recommended QoL questionnaires in allergic rhinitis and rhinoconjunctivitis are the RQLQ (or adapted versions), in chronic rhinosinusitis, the SNOT-22 or RSOM-31, and in acute rhinosinusitis, the modified SNOT-16. PROMs can be used both for daily clinical work and for research. In daily practice, a quick evaluation of the questionnaire directly indicates how the patient is doing. It makes sure that symptoms important for the patient are not overlooked and, during the consultation, the physician can elaborate on specific aspects of the symptomatology. It is important, especially in research, to realize that disease-specific questionnaires are only validated for specific diseases and are not automatically valid for other diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23299562     DOI: 10.1007/s11882-012-0334-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  36 in total

1.  Variability and lack of predictive ability of asthma end-points in clinical trials.

Authors:  J Zhang; C Yu; S T Holgate; T F Reiss
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

2.  Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale.

Authors:  Michael G Stewart; David L Witsell; Timothy L Smith; Edward M Weaver; Bevan Yueh; Maureen T Hannley
Journal:  Otolaryngol Head Neck Surg       Date:  2004-02       Impact factor: 3.497

Review 3.  What the asthma end points we know and love do and do not tell us.

Authors:  Allan T Luskin
Journal:  J Allergy Clin Immunol       Date:  2005-04       Impact factor: 10.793

4.  Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

Authors:  E F Juniper; A K Thompson; P J Ferrie; J N Roberts
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

5.  The impact of concomitant rhinitis on asthma-related quality of life and asthma control.

Authors:  Olivier Vandenplas; M Dramaix; G Joos; R Louis; A Michils; G Verleden; W Vincken; A-M Vints; E Herbots; C Bachert
Journal:  Allergy       Date:  2010-04-07       Impact factor: 13.146

6.  Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States.

Authors:  Neil Bhattacharyya
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-07       Impact factor: 1.547

7.  Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

Authors:  E F Juniper; G H Guyatt
Journal:  Clin Exp Allergy       Date:  1991-01       Impact factor: 5.018

8.  A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis.

Authors:  Elizabeth F Juniper; Thomas Rohrbaugh; Eli O Meltzer
Journal:  J Allergy Clin Immunol       Date:  2003-03       Impact factor: 10.793

9.  Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate.

Authors:  Jay S Rechtweg; Rizwan Moinuddin; Steven M Houser; Bulent Mamikoglu; Jacquelynne P Corey
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

10.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

View more
  13 in total

Review 1.  Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.

Authors:  Lei Cheng; Jianjun Chen; Qingling Fu; Shaoheng He; Huabin Li; Zheng Liu; Guolin Tan; Zezhang Tao; Dehui Wang; Weiping Wen; Rui Xu; Yu Xu; Qintai Yang; Chonghua Zhang; Gehua Zhang; Ruxin Zhang; Yuan Zhang; Bing Zhou; Dongdong Zhu; Luquan Chen; Xinyan Cui; Yuqin Deng; Zhiqiang Guo; Zhenxiao Huang; Zizhen Huang; Houyong Li; Jingyun Li; Wenting Li; Yanqing Li; Lin Xi; Hongfei Lou; Meiping Lu; Yuhui Ouyang; Wendan Shi; Xiaoyao Tao; Huiqin Tian; Chengshuo Wang; Min Wang; Nan Wang; Xiangdong Wang; Hui Xie; Shaoqing Yu; Renwu Zhao; Ming Zheng; Han Zhou; Luping Zhu; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2018-07       Impact factor: 5.764

2.  Predictive factors of a beneficial quality of life outcome in patients undergoing primary sinonasal surgery: a population-based prospective cohort study.

Authors:  Antti I Alakärppä; Timo J Koskenkorva; Petri T Koivunen; Olli-Pekka Alho
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-28       Impact factor: 2.503

Review 3.  Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.

Authors:  Huabin Li; Shi Chen; Lei Cheng; Yinshi Guo; He Lai; Yong Li; Xiaoping Lin; Zheng Liu; Qianhui Qiu; Jie Shao; Li Shi; Man Tian; Chengshuo Wang; Hongtian Wang; Xueyan Wang; Qingyu Wei; Yongxiang Wei; Li Xiang; Qintai Yang; Changqing Zhao; Huanping Zhang; Yuxiang Zhi; Junxiao Gao; Quansheng Li; Juan Liu; Kuiji Wang; Wencheng Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Quality of life before and after sinonasal surgery: a population-based matched cohort study.

Authors:  Antti I Alakärppä; Timo J Koskenkorva; Petri T Koivunen; Olli-Pekka Alho
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

5.  Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations.

Authors:  R D Divekar; S Samant; M A Rank; J Hagan; D Lal; E K O'Brien; H Kita
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

6.  T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients.

Authors:  Nithin D Adappa; Alan D Workman; Denis Hadjiliadis; Daniel J Dorgan; Danielle Frame; Steven Brooks; Laurel Doghramji; James N Palmer; Corrine Mansfield; Danielle R Reed; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-17       Impact factor: 3.858

7.  Influence of self-reported chronic rhinosinusitis on health-related quality of life: a population-based survey.

Authors:  Qing-Ling Fu; Jin-Xiang Ma; Chun-Quan Ou; Cui Guo; Shuang-Quan Shen; Geng Xu; Jianbo Shi
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

8.  Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre.

Authors:  J van der Veen; S F Seys; M Timmermans; P Levie; M Jorissen; W J Fokkens; P W Hellings
Journal:  Allergy       Date:  2016-09-15       Impact factor: 13.146

Review 9.  Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis.

Authors:  Zheng Liu; Jianjun Chen; Lei Cheng; Huabin Li; Shixi Liu; Hongfei Lou; Jianbo Shi; Ying Sun; Dehui Wang; Chengshuo Wang; Xiangdong Wang; Yongxiang Wei; Weiping Wen; Pingchang Yang; Qintai Yang; Gehua Zhang; Yuan Zhang; Changqing Zhao; Dongdong Zhu; Li Zhu; Fenghong Chen; Yi Dong; Qingling Fu; Jingyun Li; Yanqing Li; Chengyao Liu; Feng Liu; Meiping Lu; Yifan Meng; Jichao Sha; Wenyu She; Lili Shi; Kuiji Wang; Jinmei Xue; Luoying Yang; Min Yin; Lichuan Zhang; Ming Zheng; Bing Zhou; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

10.  The effectiveness and safety of acupuncture for allergic rhinitis: Protocol for an overview of systematic reviews and meta-analyses.

Authors:  Jun Yang; Jun Xiong; Xue Wang; Ting Yuan; Yong Fu; Yunfeng Jiang; Xiaohong Zhou; Kai Liao; Lingling Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.